申请人:Schering Aktiengesellschaft
公开号:US05746995A1
公开(公告)日:1998-05-05
The invention relates to new diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 or 57-83, pharmaceutical agents that contain these compounds and their use as contrast media and antidotes.
该发明涉及新的二乙烯三胺五乙酸衍生物,它们的络合物和络合盐,包含原子序数为20-32、39-51或57-83的元素,含有这些化合物的药物剂以及它们作为造影剂和解毒剂的用途。